Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1409

1.

Fecal microbiota transplantation in refractory ulcerative colitis - a case report.

Moutinho BD, Baima JP, Rigo FF, Saad-Hossne R, Rodrigues J, Romeiro FG, Sassaki LY.

J Int Med Res. 2019 Jan 11:300060518821790. doi: 10.1177/0300060518821790. [Epub ahead of print]

PMID:
30632438
2.

Epstein-Barr virus-associated hemophagocytic syndrome in a patient with ulcerative colitis during treatment with azathioprine: A case report and review of literature.

Miyaguchi K, Yamaoka M, Tsuzuki Y, Ashitani K, Ohgo H, Miyagawa Y, Ishizawa K, Kayano H, Nakamoto H, Imaeda H.

World J Clin Cases. 2018 Nov 26;6(14):776-780. doi: 10.12998/wjcc.v6.i14.776.

3.

Autoimmune pancreatitis in children: A single centre experience in diagnosis, management and long term follow up.

Lee HM, Deheragoda M, Harrison P, Devlin J, Sellars M, Hadzic N, Dhawan A, Grammatikopoulos T.

Pancreatology. 2018 Nov 14. pii: S1424-3903(18)30751-8. doi: 10.1016/j.pan.2018.11.004. [Epub ahead of print]

PMID:
30455055
4.

Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial.

Papada E, Forbes A, Amerikanou C, Torović L, Kalogeropoulos N, Tzavara C, Triantafillidis JK, Kaliora AC.

Nutrients. 2018 Nov 16;10(11). pii: E1779. doi: 10.3390/nu10111779.

5.

Statin Use is Associated with Improved Outcomes of Patients With Primary Sclerosing Cholangitis.

Stokkeland K, Höijer J, Bottai M, Söderberg-Löfdal K, Bergquist A.

Clin Gastroenterol Hepatol. 2018 Nov 15. pii: S1542-3565(18)31245-X. doi: 10.1016/j.cgh.2018.11.002. [Epub ahead of print]

PMID:
30448601
6.

Biochemical Markers, Genotype, and Inflammation in Pediatric Inflammatory Bowel Disease: A Danish Population-Based Study.

Ziade F, Rungoe C, Kallemose T, Paerregaard A, Wewer AV, Jakobsen C.

Dig Dis. 2019;37(2):140-146. doi: 10.1159/000494215. Epub 2018 Nov 13.

PMID:
30423580
7.

[Pancytopenia associated with thioguanine use].

van der Burg M, Gerding MN.

Ned Tijdschr Geneeskd. 2018 Oct 18;162. pii: D2839. Dutch.

PMID:
30379500
8.

Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease.

Lee JM, Kim YJ, Lee KM, Yoon H, Lee BI, Kim DB, Kang D.

Scand J Gastroenterol. 2018 Oct 23:0-6. doi: 10.1080/00365521.2018.1524024. [Epub ahead of print]

PMID:
30351977
9.

Prognostic value of the burden of cytomegalovirus colonic reactivation evaluated by immunohistochemical staining in patients with active ulcerative colitis.

Clos-Parals A, Rodríguez-Martínez P, Cañete F, Mañosa M, Ruiz-Cerulla A, Paúles MJ, Llaó J, Gordillo J, Fumagalli C, Garcia-Planella E, Ojanguren I, Cabré E, Guardiola J, Domènech E.

J Crohns Colitis. 2018 Oct 20. doi: 10.1093/ecco-jcc/jjy173. [Epub ahead of print]

PMID:
30346606
10.

Fecal Microbiota Transplantation to Patients with Refractory Very Early Onset Ulcerative Colitis.

Yodoshi T, Hurt TL.

Pediatr Gastroenterol Hepatol Nutr. 2018 Oct;21(4):355-360. doi: 10.5223/pghn.2018.21.4.355. Epub 2018 Oct 10.

11.

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort.

Bálint A, Rutka M, Kolar M, Bortlik M, Duricova D, Hruba V, Lukas M, Mitrova K, Malickova K, Lukas M, Szepes Z, Nagy F, Palatka K, Lovas S, Végh Z, Kürti Z, Csontos Á, Miheller P, Nyári T, Bor R, Milassin Á, Fábián A, Szántó K, Lakatos PL, Molnár T, Farkas K.

Expert Opin Biol Ther. 2018 Nov;18(11):1181-1187. doi: 10.1080/14712598.2018.1530758. Epub 2018 Oct 9.

PMID:
30277084
12.

Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.

Johnson CM, Dassopoulos T.

Curr Gastroenterol Rep. 2018 Sep 28;20(11):53. doi: 10.1007/s11894-018-0658-1. Review.

PMID:
30267281
13.

Nonbiological therapeutic management of ulcerative colitis.

Mezzina N, Campbell Davies SE, Ardizzone S.

Expert Opin Pharmacother. 2018 Nov;19(16):1747-1757. doi: 10.1080/14656566.2018.1525361. Epub 2018 Sep 27. Review. Erratum in: Expert Opin Pharmacother. 2018 Dec;19(18):2095.

PMID:
30220228
14.

A Concise History of Thiopurines for Inflammatory Bowel Disease: from Anecdotal Reporting to Treat-to-Target Algorithms.

Actis GC, Pellicano R, Ribaldone DG.

Rev Recent Clin Trials. 2018 Sep 10. doi: 10.2174/1574887113666180910120959. [Epub ahead of print]

PMID:
30198438
15.

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.

Hanauer SB, Sandborn WJ, Lichtenstein GR.

Gastroenterology. 2019 Jan;156(1):36-42. doi: 10.1053/j.gastro.2018.08.043. Epub 2018 Sep 7.

PMID:
30195449
16.
17.

Recent advances and emerging therapies in the non-surgical management of ulcerative colitis.

Wehkamp J, Stange EF.

F1000Res. 2018 Aug 7;7. pii: F1000 Faculty Rev-1207. doi: 10.12688/f1000research.15159.1. eCollection 2018. Review.

18.

The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.

Paschou SA, Palioura E, Kothonas F, Myroforidis A, Loi V, Poulou A, Goumas K, Effraimidis G, Vryonidou A.

Endocr J. 2018 Nov 29;65(11):1121-1125. doi: 10.1507/endocrj.EJ18-0243. Epub 2018 Aug 21.

19.

The treatment of refractory ulcerative colitis.

Pineton de Chambrun G, Tassy B, Kollen L, Dufour G, Valats JC, Bismuth M, Funakoshi N, Panaro F, Blanc P.

Best Pract Res Clin Gastroenterol. 2018 Feb - Apr;32-33:49-57. doi: 10.1016/j.bpg.2018.05.009. Epub 2018 May 18. Review.

PMID:
30060939
20.

Table: safety of drugs for IBD in pregnancy.

[No authors listed]

Med Lett Drugs Ther. 2018 Jul 2;60(1550):e116. No abstract available.

PMID:
30036355

Supplemental Content

Loading ...
Support Center